nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical research on rare diseases of children: neuroblastoma
|
Gerardi, Chiara |
|
2016 |
79 |
2 |
p. 267-273 |
artikel |
2 |
Comment to: GSTP1, GSTM1 and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis
|
Cargnin, Sarah |
|
2017 |
79 |
2 |
p. 435-436 |
artikel |
3 |
Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205
|
Zhang, Hong-Yan |
|
2017 |
79 |
2 |
p. 327-337 |
artikel |
4 |
Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box?
|
Ribeiro, Mariana P. C. |
|
2016 |
79 |
2 |
p. 219-225 |
artikel |
5 |
Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues
|
Mayo, Bronwen J. |
|
2016 |
79 |
2 |
p. 233-249 |
artikel |
6 |
Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect?
|
Cohen, Ian Joseph |
|
2017 |
79 |
2 |
p. 437 |
artikel |
7 |
Modulation of cyclophosphamide-induced cardiotoxicity by methyl palmitate
|
El-Agamy, Dina S. |
|
2017 |
79 |
2 |
p. 399-409 |
artikel |
8 |
Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents
|
Alagumuthu, Manikandan |
|
2017 |
79 |
2 |
p. 389-397 |
artikel |
9 |
Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice
|
Zenitani, Masahiro |
|
2017 |
79 |
2 |
p. 363-368 |
artikel |
10 |
On-treatment markers as predictors to guide anti-EGFR MoAb treatment in metastatic colorectal cancer: a systematic review with meta-analysis
|
Hu, Jing |
|
2016 |
79 |
2 |
p. 275-285 |
artikel |
11 |
Pharmacokinetic and exposure–response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer
|
Quartino, Angelica L. |
|
2017 |
79 |
2 |
p. 353-361 |
artikel |
12 |
Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1)
|
Saif, Muhammad Wasif |
|
2016 |
79 |
2 |
p. 303-314 |
artikel |
13 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, Ghassan K. |
|
2017 |
79 |
2 |
p. 421-429 |
artikel |
14 |
Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report
|
Coller, Janet K. |
|
2016 |
79 |
2 |
p. 431-434 |
artikel |
15 |
Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways
|
Liebig, Hannes |
|
2017 |
79 |
2 |
p. 411-420 |
artikel |
16 |
Research progress of hydroxychloroquine and autophagy inhibitors on cancer
|
Shi, Ting-Ting |
|
2016 |
79 |
2 |
p. 287-294 |
artikel |
17 |
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
|
Sarantopoulos, John |
|
2017 |
79 |
2 |
p. 339-351 |
artikel |
18 |
Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer
|
Tabchi, Samer |
|
2017 |
79 |
2 |
p. 381-387 |
artikel |
19 |
The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer
|
Zang, Hongjing |
|
2016 |
79 |
2 |
p. 227-231 |
artikel |
20 |
The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy
|
Chen, Jianli |
|
2017 |
79 |
2 |
p. 369-380 |
artikel |
21 |
Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors
|
Ajorlou, Elham |
|
2016 |
79 |
2 |
p. 251-265 |
artikel |
22 |
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer
|
Infante, Jeffrey R. |
|
2017 |
79 |
2 |
p. 315-326 |
artikel |
23 |
Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
|
Moreb, Jan S. |
|
2016 |
79 |
2 |
p. 295-301 |
artikel |